-
How P-gp Inhibition Raises Luteolin Bioavailability
2026-09-01
The reference study developed a luteolin-loaded self-microemulsifying drug delivery system that combines improved dispersion with D-α-tocopheryl polyethylene glycol 1000 succinate-mediated inhibition of P-glycoprotein efflux. The formulation enhanced Caco-2 cellular uptake, showed favorable preliminary biosafety, and increased luteolin systemic exposure by 29-fold in pharmacokinetic testing, providing a useful model for oral delivery of poorly absorbed bioactives.
-
GSK 2837808A LDHA Inhibition Workflows
2026-09-01
GSK 2837808A is a selective LDHA tool for separating lactate production from broader glycolytic activity in cancer-cell experiments. This workflow connects validated hepatocellular carcinoma applications with carefully bounded, hypothesis-generating studies of lactate-linked immune signaling in colorectal cancer.
-
Nicotinamide Adenine Dinucleotide in Stress Assays
2026-08-31
Use NAD+ to add a quantitative metabolic layer to studies of caspase-dependent autophagy and DNA damage responses. This workflow combines controlled NAD+ handling with NAD+/NADH measurements, autophagy readouts, PARP1 processing, and H2AX phosphorylation to distinguish metabolic adaptation from lethal stress.
-
In Vitro Drug Response Metrics in Cancer Research
2026-08-31
Hannah R. Schwartz’s dissertation separates relative viability from fractional viability to clarify how cancer drugs produce growth arrest and cell killing. Its central implication is practical: drug-response studies should measure proliferation and death as related but distinct outcomes, ideally across time rather than at one endpoint.
-
Merimepodib (VX-497) Research Workflows
2026-08-30
Merimepodib (VX-497) enables controlled IMPDH inhibition for antiviral, lymphocyte, and proliferation assays. This workflow guide translates recent PEDV metabolism findings into practical experimental design, controls, and troubleshooting strategies.
-
ARCA EGFP mRNA: Storage-to-Assay Guide
2026-08-29
ARCA EGFP mRNA (5-moUTP) is a polyadenylated mRNA reporter for controlled fluorescence readouts in mammalian cells. This guide connects molecular design with storage, handling, assay architecture, and the practical limits of translating LNP-RNA stability findings to reporter workflows.
-
Cyclic di-GMP: Biofilm and STING Workflows
2026-08-28
Cyclic di-GMP connects bacterial biofilm persistence studies with mammalian STING-based immune modulation. This practical guide covers formulation, assay design, protocol starting points, controls, and troubleshooting for infection biology and cancer immunotherapy research.
-
Merimepodib (VX-497) IMPDH Research Workflow
2026-08-28
Merimepodib (VX-497) provides a reversible way to interrogate IMPDH-dependent guanine nucleotide biosynthesis in antiviral, lymphocyte, and cell-proliferation models. This applied guide connects formulation, dose selection, orthogonal validation, and troubleshooting to recent evidence that PEDV depends on host IMPDH activity.
-
Dual-Action Inhibitors and p38α Dephosphorylation
2026-08-27
The reference study shows that kinase inhibitors can do more than block p38α catalytic activity: selected compounds also expose the activation-loop phospho-threonine and accelerate its removal by WIP1. By combining biochemical dephosphorylation assays with X-ray crystallography, the work establishes kinase conformation as a potential lever for improving inhibitor specificity, durability, and pathway control.
-
MK-1775: Wee1 Kinase Inhibitor Workflow
2026-08-27
Use MK-1775 to interrogate Wee1-dependent checkpoint control, then separate growth arrest from true cell killing with orthogonal readouts. This workflow is especially useful for testing DNA-damage combinations in p53-deficient models without overinterpreting a single viability endpoint.
-
Multiple Myeloma Cell Lines: Mutations and Drug Response
2026-08-26
Vikova and colleagues used whole-exome sequencing across a genetically diverse panel of human multiple myeloma cell lines to define recurrent coding mutations, altered pathways, and links to drug response. The study provides a practical framework for selecting cell-line models and developing hypotheses about disease progression and treatment resistance.
-
BOP Reagent Workflow for Peptide and Prodrug Synthesis
2026-08-26
BOP reagent supports controlled carboxyl group activation for amide bond formation, phenyl ester preparation, and blocked amino acid derivative workflows. This article connects practical coupling design with the carrier-free triterpene prodrug strategy reported for oral squamous cell carcinoma, while clearly separating established chemistry from forward-looking applications.
-
G007-LK: From Tankyrase Biology to Translation
2026-08-25
G007-LK is a selective tankyrase 1/2 inhibitor that connects TNKS1/2 enzymatic control with AXIN stabilization, β-catenin degradation induction, and Hippo pathway modulation. This thought-leadership guide helps translational researchers design stronger mechanistic studies across APC mutation colorectal cancer research and hepatocellular carcinoma models while keeping pharmacologic and clinical limitations in view.
-
Tetrandrine Workflows for Ion Channel Research
2026-08-25
Build reproducible Tetrandrine assays for calcium-channel signaling, inflammation, and cancer biology research with practical stock-preparation and troubleshooting guidance. The workflow also shows how to distinguish membrane-targeted experiments from computational natural-product screening claims.
-
RNA Clean and Concentrator Kit: Workflow Guide
2026-08-24
The RNA Clean and Concentrator Kit is a membrane-based RNA purification spin column workflow for rapid cleanup of RNA from enzymatic reactions. The K1069 format is optimized for single-stranded RNA longer than 100 nucleotides and double-stranded RNA longer than 200 base pairs across a stated recovery range of 1 ng to 500 μg.